Skip to main content

Standard Biotools Inc.

LAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001162194

No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Standard Biotools Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of LAB: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders6672+6
Shares46.2M47.4M+1.27M (+2.8%)
Value$89.1M$137.5M+$48.5M (+54.4%)

New holders (15)

Institutions that held Standard Biotools Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to LAB in Q3 2023
InstitutionSharesValue% of portfolio
Hollow Brook Wealth Management LLC1,785,757$5.18M2.16%
Parkman Healthcare Partners LLC500,000$1.45M0.27%
EAM Investors, LLC473,982$1.37M0.27%
Citigroup Inc189,791$550.4K0.00%
Schonfeld Strategic Advisors LLC143,000$414.7K0.00%
Jefferies Financial Group Inc.56,400$163.6K0.00%
Barclays PLC48,194$139.8K0.00%
Point72 Asset Management, L.P.34,582$100.3K0.00%
Jump Financial, LLC32,450$94.1K0.00%
Freedom Wealth Alliance, LLC20,394$59.1K0.10%
Qube Research & Technologies Ltd19,085$55.3K0.00%
Acadian Asset Management LLC17,610$50.0K0.00%
Prudential Financial Inc15,000$43.5K0.00%
Comerica Bank1,161$3.37K0.00%
Federated Hermes, Inc.498$1.44K0.00%

Sold out (9)

Institutions that held Standard Biotools Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of LAB in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Tudor Investment Corp Et Al85,058$164.2K
Mirador Capital Partners LP47,956$92.6K
Occudo Quantitative Strategies LP32,954$63.6K
Walleye Capital LLC20,535$39.6K
Cerity Partners LLC12,588$24.3K
HRT Financial LP11,877$22.0K
First Horizon Advisors, Inc.3,000$5.79K
Repertoire Partners LP100$193
CWM, LLC81$0